PYC Therapeutics Limited (AU:PYC) has released an update.
PYC Therapeutics Limited is gearing up to host an informative investor webinar on the 30th of August 2024, aiming to share the company’s advancements achieved in the current year. The clinical-stage biotech firm, known for developing novel RNA therapies for genetic diseases, has multiple clinical trials underway and is preparing for a new trial in early 2025. Interested shareholders can join the event either in person in Western Australia or through a provided online link.
For further insights into AU:PYC stock, check out TipRanks’ Stock Analysis page.